MLAB Mesa Laboratories Inc.

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

LAKEWOOD, Colo., May 31, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously communicated. The earnings announcement has been delayed as we work to finalize our year end audit which is focused on finalizing the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to our Clinical Genomics and Biopharmaceutical Development divisions and the purchase accounting associated with the acquisition of GKE.

Mesa’s Form 10-K filing deadline with the SEC is June 14, 2024.

About Mesa Laboratories, Inc.

Mesa is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

For more information about the Company, please visit our website at .





CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both of Mesa Laboratories, Inc.,
EN
31/05/2024

Underlying

MLABMesa Laboratories Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mesa Laboratories Inc.

 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year (“FY24”) ended March 31, 2024 (amounts in thousands). Fourth quarter FY24 compared to fourth quarter FY23: Revenues increased 6% and increased 10.2% vs 3Q24Non-GAAP core organic revenues1 decreased 3.5%Operating (loss) was $(271,284) which inc...

June 5, 2024 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudit...

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results LAKEWOOD, Colo., May 31, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously communicated. The earnings announcement has been delayed as we work to finalize our year end audit which is focused on finalizing the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill relate...

May 31, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.55
NFG National Fuel G...
MLAB Mesa Laboratori... ... (+27)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

NFG NATIONAL FUEL GAS COMPANY
MLAB MESA LABORATORIES INC.
LOCO EL POLLO LOCO HOLDINGS INC
JWN NORDSTROM INC.
HNRG HALLADOR ENERGY CO.
EQT EQT CORPORATION
CRK COMSTOCK RESOURCES INC.
AROW ARROW FINANCIAL CORP.
PRA PROASSURANCE CORPORATION
VMI VALMONT INDUSTRIES INC.
ZUMZ ZUMIEZ INC.
KIDS ORTHOPEDIATRICS CORP
FNKO FUNKO CLASS A
ST SENSATA TECHNOLOGIES HOLDING PLC
LOVE LOVESAC
GH GUARDANT HEALTH
WOOF PETCO HEALTH AND WELLNESS
SGHT SIGHT SCIENCES INC
BRCC BRC INC
BORR BORR DRILLING LTD
PFHC PROFRAC HLDG CORP
OBIO ORCHESTRA BIOMED HOLDINGS INC
BG BUNGE LIMITED
RNAC CARTESIAN THERAPEUTICS INC
AGEN AGENUS INC.
GIII G III APPAREL GROUP LTD COM
RVTTY ROVIO ENTERTAINMENT OYJ UNSPONS ADR
05/30/24 May 30, 2024 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudit...

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024 LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024. Mesa’s Form 10-K will be filed the same day. The earnings announcement has been delayed as we finalize the calculations and technical accounting for previously-announced impairmen...

May 22, 2024 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SEN...

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing of its Amended and Restated Credit Agreement (the “Credit Agreement”), which provides up to $200 million of senior secured debt through a syndicate of banks led by JPMORGAN CHASE BANK, N.A. The Credit Agreement includes a $75 million senior secured term loan facility (the “Term Loan”) and a $125 million senior secured revolving credit facility ...

April 8, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch